Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

Authors

Institutions

Publication Details

Journal
Clinical Pharmacokinetics
Published
2024-12-21
DOI
https://doi.org/10.1007/s40262-024-01462-4
Citations
1
Primary Topic
Pharmacogenetics and Drug Metabolism
Type
article
Field-Weighted Citation Impact
0.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

Adi Lahat, Jasmina Kalabic, Ronilda D’Cunha, Yinuo Pang et al.
1 citations
Clinical Pharmacokinetics
Pharmacogenetics and Drug Metabolism
0.47
article

Evaluation of the Effect of Risankizumab on the Pharmacokinetics of Cytochrome P450 Substrates in Patients with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

Adi Lahat, Jasmina Kalabic, Ronilda D’Cunha, Yinuo Pang, Toni Anschutz, Tofial Azam
article en
1 citations

Abstract

No abstract available for this paper.
Clinical PharmacokineticsVol. 64(1)
Ben-Gurion University of the Negev (IL), Tel Aviv University (IL), Sheba Medical Center (IL), AbbVie (United States) (US), AbbVie (Germany) (DE)
AbbVie
Good health and well-being
Openalex Percentile: Top 31%
Pharmacogenetics and Drug Metabolism
0.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.